Purdue Pharma files new bankruptcy plan for $7.4 billion opioid settlement
Bankrupt drugmaker Purdue Pharma filed a new bankruptcy plan on Tuesday, a major step toward finalizing a proposed opioid ...
Purdue Pharma Files New Bankruptcy Plan—Includes Up To $7 Billion From Sacklers
The new plan allows plaintiffs who sued Purdue to opt in to receive their settlement or reserve their right to file a civil ...
A New Study Adds to the Evidence That Drug Busts Result in More Overdose Deaths
The researchers found that drug seizures in San Francisco were associated with a substantial increase in fatal opioid ...
Standard-Examiner1d
Weber County jail launches expanded medication-assisted treatment for opioid addiction
People who are incarcerated at the Weber County Correctional Facility and struggling with opioid use disorder now have access ...
Fewer deaths, new substances and evolving treatments in Philly’s opioid epidemic − 4 essential reads
In Philadelphia, fatal overdoses are the No. 3 cause of death after heart disease and cancer. That’s been the case each year ...
Knowridge Science Report13d
Should you use opioid drugs for chronic pain?
Chronic pain, which lasts for three months or longer, is difficult to treat. Many people rely on opioid pain medications, but ...
Emergency department treatment with buprenorphine puts people struggling with opioid use disorder on path to long-term recovery
Patients who struggle with opioid addiction and who are treated by California emergency department physicians are remarkably ...
BioCorRx Pharmaceuticals Inc. Announces That it has Acquired LUCEMYRA(R) (lofexidine), an FDA-Approved Opioid Withdrawal Medication, From USWM, LLC
BioCorRx Inc. (OTCQB: BICX) (the "Company"), a developer and provider of innovative treatment programs for substance abuse and related disorders and USWM LLC, a specialty ...